Hirotani Y - Search Results

1

Protective effects of lactoferrin against intestinal mucosal damage induced by lipopolysaccharide in human intestinal Caco-2 cells.

Hirotani Y, Ikeda K, Kato R, Myotoku M, Umeda T, Ijiri Y, Tanaka K. Hirotani Y, et al. Yakugaku Zasshi. 2008 Sep;128(9):1363-8. doi: 10.1248/yakushi.128.1363. Yakugaku Zasshi. 2008. PMID: 18758152

2

Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells.

Tsukura Y, Mori M, Hirotani Y, Ikeda K, Amano F, Kato R, Ijiri Y, Tanaka K. Tsukura Y, et al. Among authors: hirotani y. Biol Pharm Bull. 2007 Oct;30(10):1982-6. doi: 10.1248/bpb.30.1982. Biol Pharm Bull. 2007. PMID: 17917278

3

Changes of the peptide YY levels in the intestinal tissue of rats with experimental colitis following oral administration of mesalazine and prednisolone.

Hirotani Y, Mikajiri K, Ikeda K, Myotoku M, Kurokawa N. Hirotani Y, et al. Yakugaku Zasshi. 2008 Sep;128(9):1347-53. doi: 10.1248/yakushi.128.1347. Yakugaku Zasshi. 2008. PMID: 18758150

4

Changes of intestinal mucosal and plasma PYY in a diarrhea model rat and influence of loperamide as the treatment agent for diarrhea.

Hirotani Y, Mikajiri K, Ikeda K, Myotoku M, Kurokawa N. Hirotani Y, et al. Yakugaku Zasshi. 2008 Sep;128(9):1311-6. doi: 10.1248/yakushi.128.1311. Yakugaku Zasshi. 2008. PMID: 18758145

5

Changes in digoxin pharmacokinetics treated with lipopolysaccharide in Wistar rats.

Kato R, Fujiwara A, Kawai T, Moriguchi J, Nakagawa M, Tsukura Y, Uchida K, Amano F, Hirotani Y, Ijiri Y, Tanaka K. Kato R, et al. Among authors: hirotani y. Biol Pharm Bull. 2008 Jun;31(6):1221-5. doi: 10.1248/bpb.31.1221. Biol Pharm Bull. 2008. PMID: 18520058

6

Effects of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on intestinal function in streptozotocin-induced diabetic rats.

Hirotani Y, Ikeda T, Ikeda K, Yamamoto K, Onda M, Arakawa Y, Li J, Kitamura K, Kurokawa N. Hirotani Y, et al. Yakugaku Zasshi. 2007 Sep;127(9):1509-13. doi: 10.1248/yakushi.127.1509. Yakugaku Zasshi. 2007. PMID: 17827932

7

Effects of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on hyperglycemia in streptozotocin-induced diabetic rats.

Hirotani Y, Ikeda T, Yamamoto K, Kurokawa N. Hirotani Y, et al. Biol Pharm Bull. 2007 May;30(5):1015-20. doi: 10.1248/bpb.30.1015. Biol Pharm Bull. 2007. PMID: 17473455

8

Effects of lipopolysaccharide on intestinal P-glycoprotein expression and activity.

Moriguchi J, Kato R, Nakagawa M, Hirotani Y, Ijiri Y, Tanaka K. Moriguchi J, et al. Among authors: hirotani y. Eur J Pharmacol. 2007 Jun 22;565(1-3):220-4. doi: 10.1016/j.ejphar.2007.02.058. Epub 2007 Mar 12. Eur J Pharmacol. 2007. PMID: 17399699

9

Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats.

Shimeda Y, Hirotani Y, Akimoto Y, Shindou K, Ijiri Y, Nishihori T, Tanaka K. Shimeda Y, et al. Among authors: hirotani y. Biol Pharm Bull. 2005 Sep;28(9):1635-8. doi: 10.1248/bpb.28.1635. Biol Pharm Bull. 2005. PMID: 16141530

10

Correlation between plasma glucagon-like peptide 2 levels and proliferative makers in small intestinal injury in rats induced by methotrexate administration.

Hirotani Y, Yamamoto K, Ikeda K, Arakawa Y, Li J, Kitamura K, Kurokawa N, Tanaka K. Hirotani Y, et al. Biol Pharm Bull. 2006 Nov;29(11):2327-30. doi: 10.1248/bpb.29.2327. Biol Pharm Bull. 2006. PMID: 17077541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results